Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SF 205Sesión 2025-2026

Qué cambió entre versiones

5 párrafos cambiaron+22 palabras agregadas−6 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

House

19 párrafos sin cambios

Senate

Joint

Schedules

Committees

Bills

Law

Multimedia

Publications

Office of the Revisor of Statutes

Retrieve by number Document type Statutes Laws Rules Bills GO

Statutes

Laws

Rules

Court Rules

Constitution

Revisor's Office Revisor Intranet Attorney Drafting Areas Staff Directory Office Duties Publications Educational Seminars Employment Openings Order Publications

Search Law by Keyword

Bills

94th Legislature (2025 - 2026)

SF205

Introduction

1st Engrossment

SF 205

Introduction1st Engrossment - 94th Legislature (2025 - 2026)

Posted on 03/0711/2025 0209:3133 pa.m.

Bill Text Versions

13 párrafos sin cambios

Engrossments

Introduction PDF

Posted on 01/15/2025

1st Engrossment PDF

Posted on 03/10/2025

A bill for an act relating to health; prohibiting prior authorization of antineoplastic cancer treatment; amending Minnesota Statutes 2024, section 62M.07, subdivision 2.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 62M.07, subdivision 2, is amended to read:

Subd. 2.

Prior authorization of certain services prohibited.

No utilization review organization, health plan company, or claims administrator may conduct or require prior authorization of:

(1) emergency confinement or an emergency service. The enrollee or the enrollee's authorized representative may be required to notify the health plan company, claims administrator, or utilization review organization as soon as reasonably possible after the beginning of the emergency confinement or emergency service;

(2) outpatient mental health treatment or outpatient substance use disorder treatment, except for treatment which is a medication. Prior authorizations required for medications used for outpatient mental health treatment or outpatient substance use disorder treatment must be processed according to section 62M.05, subdivision 3b, for initial determinations, and according to section 62M.06, subdivision 2, for appeals;

(3) antineoplastic cancer treatment that is consistent with guidelines of the National Comprehensive Cancer Network new text begin or nationally and internationally accepted standards of care new text end , deleted text begin except fordeleted text end new text begin including but not limited to new text end treatment deleted text begin whichdeleted text end new text begin that new text end is a medicationdeleted text begin . Prior authorizations required for medications used for antineoplastic cancer treatment must be processed according to section 62M.05, subdivision 3b, for initial determinations, and according to section 62M.06, subdivision 2, for appealsdeleted text end ;

(4) services that currently have a rating of A or B from the United States Preventive Services Task Force, immunizations recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, or preventive services and screenings provided to women as described in Code of Federal Regulations, title 45, section 147.130;

20 párrafos sin cambios

(5) pediatric hospice services provided by a hospice provider licensed under sections 144A.75 to 144A.755; and

(6) treatment delivered through a neonatal abstinence program operated by pediatric pain or palliative care subspecialists.

Clauses (2) to (6) are effective January 1, 2026, and apply to health benefit plans offered, sold, issued, or renewed on or after that date.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective January 1, 2027, and applies to health benefit plans offered, sold, issued, or renewed on or after that date. new text end

Historical Information

Employment/Internships

Visiting the Capitol

Accessibility

Frequently Asked Questions

Who Represents Me?

House Members

Senators

Contact a legislative librarian:

(651) 296-8338 or Email

Phone Numbers

Submit website comments

House News

Senate News

MyBills

Email Updates & RSS Feeds

Volver al texto completo